“Dushu Lake Prize”Selection of China Pharmaceutical Innovation Brand“Dushu Lake Prize”Selection of China Pharmaceutical Innovation Brand

010-58156160-822

CN
Introduction

To facilitate the internationalization of Chinese innovative brands by promoting and implementing the national Innovation Driven Development Strategy, enhancing the core competitiveness of innovative technology and advancing the process of strengthening the nation by technology and pharmaceutical development, China Pharmaceutical Innovation and Research Development Association (PhIRDA) and Suzhou Industrial Park have reached a consensus on co-hosting the “Dushu Lake Prize” Selection Activities of China Pharmaceutical Innovation Brand (herein after referred to as the Selection Activities) in 2018. Both sides will join hands to make the Selection Activities a fair, just, and open session.

The Selection Activities adopts the mechanism of expert recommendation. Any applications from enterprises shall not be taken into consideration. The selection will follow the peer review system of international innovation standards and scientific awards to set the awards for the most innovative drugs, figures (Chinese scientists) and financial institutions.

Experts List
Awards List
Awards List

Sang Guowei, Academician of Chinese Academy of Engineering, Chief Engineer of National Key Project on Innovation and Development of Major New Drugs

Awards List

Chemical Drug: Chidamide (Epidaza)-Shenzhen Chipscreen Biosciences, Ltd.
Biological Drug: Recombinant Human Prourokinase for Injection-Shanghai Tasly Pharmaceutical Co., Ltd.
Traditional Chinese Medicine: Ginkgolide Injection-Chengdu Baiyu Pharmaceutical Co., Ltd.

Awards List

Entecavir API and Dispersible Tablets-Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Docetaxel Injection-Jiangsu Hengrui Medicine Co., Ltd.
Pemetrexed Disodium for Injection-Qilu Pharmaceutical Co., Ltd.

Awards List

Manufacturing: LUYE Pharma Group Co., Ltd. | Simcere Pharmaceutical Group
R&D:Innovent Biologics (Suzhou) Co., Ltd.
Traditional Chinese Medicine: Taiji Group Co., Ltd.

Awards List

Su Weiguo, Chief Scientific Officer, Hutchison MediPharma Limited

Awards List

Cui Yimin, Director of Clinical Trial Center, Peking University First Hospital

Awards List

Ding Lieming, Chairman of the Board&CEO, Betta Pharmaceutical Co., Ltd.
Xiao Wei, Chairman of the Board, Jiangsu Kanion Pharmaceutical Co., Ltd.

Video of 2016 Selection
Photos of 2016 Selection
Contact Us

Office of Selection Activities

Zhang Lin
Tel:010-58156160-821
Mobile:157 1133 7989
E-mail:zhangl@phirda.com
Zhang Zhao
Tel:010-58156160-822
Mobile:188 1307 5508
E-mail:zhangz@phirda.com
Downloads